Скачать или смотреть I’m taking 40 grams to cut Visceral Fat and promote Liver Health

JOIN THE PHYSIONIC INSIDERS [PREMIUM CONTENT]
Join the Physionic Insiders: https://bit.ly/PhysionicInsiders2

HEALTH AUTONOMY [COURSE]
Learn to Analyze & Apply Studies for Yourself: https://bit.ly/healthautonomy

JOIN THE COMMUNITY
Join my Community [It’s Free!]: https://bit.ly/PhysionicCommunity2

EMAIL LIST
1-2 Weekly Email of Value [It’s Free!]: http://bit.ly/2AXIzK6

HIRE ME FOR CONSULTING:
Consulting: https://bit.ly/3dmUl2H

Created with Biorender

0:00 - Introduction
0:38 - Trim it, Trim it Good
2:43 - My Liver! It’s Healing!
4:21 - A Tiny Issue: Dead Bacteria, Live Bacteria
7:21 - 70% of People are even Luckier
8:37 - My Approach

Odd Fasting Method that Melts Visceral Fat:    • This Odd Fasting Method Shreds Visceral Fa...  

References
[Study 606] Ni Y, Qian L, Leal Siliceo S, et al. Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations. Cell Metab. 2023;35(9):1530-1547. doi:10.1016/j.cmet.2023.08.002

Funding/Conflict: Public funding: National Natural Science Foundation of China; National Key Research and Development Program of China (including grant 2022YFA1004804); Shanghai Municipal Key Clinical Specialty; Shanghai Research Center for Endocrine and Metabolic Diseases; Shanghai Jiao Tong University School of Medicine; Dalian Institute of Chemical Physics; Chinese Academy of Sciences; Marie Skłodowska-Curie Actions and Marie Skłodowska-Curie Innovative Training Networks; Non-Profit funding: “Key Foundation” (named as such in the funder statement, without further specification); Industry funding: none listed in the funder statement; Conflicts of interest: the authors declare no competing interests.

[Study 607] Long X, Wang H, Lu Y, et al. Interindividual variability in gut microbiome mediates the efficacy of resistant starch on MASLD. Cell Metab. 2025;37:2342-2361. doi:10.1016/j.cmet.2025.10.017

[Study 608] Li H, Zhang L, Li J, et al. Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota. Nat Metab. 2024;6(3):578-597. doi:10.1038/s42255-024-00988-y

Funding/Conflict: Public funding: National Key Research and Development Program of China (2022YFA1004804); Shanghai Municipal Key Clinical Specialty; Shanghai Research Center for Endocrine and Metabolic Diseases (2022ZZ01002); National Natural Science Foundation of China (including 81220108006, 82022012, 82270907, 92357305, 21934006); Innovative Research Team of High-level Local Universities in Shanghai (SHSMU-ZDCX20212700); Hong Kong Scholars Program (XJ2013035); Two Hundred Program from Shanghai Jiao Tong University School of Medicine; Hong Kong Research Grant Council (AOE/M/707-18); Marie Skłodowska-Curie Actions and Innovative Training Networks (H2020-MSCA-ITN-2018 813781); DFG under Germany’s Excellence Strategy (EXC 2051, project ID 390713860); Shenzhen Basic Research Program (JCYJ20190808182402941); Guangdong Basic and Applied Research Major Program (2019B030302005); Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB38020200); Youth Innovation Promotion Association of the Chinese Academy of Sciences (2021186); The Hong Kong Polytechnic University (P0042740); Non-Profit funding: none reported; Industry funding/support: study materials (Hi-Maize 260 resistant starch and AMIOCA cornstarch) were provided by Ingredion; Conflicts of interest: the authors declare no competing interests.

[Study 609] Zhang L, Ouyang Y, Li H, et al. Metabolic phenotypes and the gut microbiota in response to dietary resistant starch type 2 in normal-weight subjects: a randomized crossover trial. Sci Rep. 2019;9(1):4736. Published 2019 Mar 20. doi:10.1038/s41598-018-38216-9

[Study 610] Peterson CM, Beyl RA, Marlatt KL, et al. Effect of 12 wk of resistant starch supplementation on cardiometabolic risk factors in adults with prediabetes: a randomized controlled trial. Am J Clin Nutr. 2018;108(3):492-501. doi:10.1093/ajcn/nqy121

[Study 611] Johnston KL, Thomas EL, Bell JD, Frost GS, Robertson MD. Resistant starch improves insulin sensitivity in metabolic syndrome. Diabet Med. 2010;27(4):391-397. doi:10.1111/j.1464-5491.2010.02923.x

Please use the following link to submit your critique: https://bit.ly/PhysionicCritique

Disclaimer: None of the information provided by this brand is a replacement for your physician's advice. This brand is information for the sake of knowledge and the options of choice it provides, not in any way a personalized prescription. Please consult your physician before making any health related changes.